These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 17396228)
1. Pathogenesis, clinical and laboratory aspects of thrombosis in cancer. Franchini M; Montagnana M; Targher G; Manzato F; Lippi G J Thromb Thrombolysis; 2007 Aug; 24(1):29-38. PubMed ID: 17396228 [TBL] [Abstract][Full Text] [Related]
2. The bidirectional relationship of cancer and hemostasis and the potential role of anticoagulant therapy in moderating thrombosis and cancer spread. Franchini M; Montagnana M; Favaloro EJ; Lippi G Semin Thromb Hemost; 2009 Oct; 35(7):644-53. PubMed ID: 20013531 [TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression. Rak J; Klement P; Yu J Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463 [TBL] [Abstract][Full Text] [Related]
4. Overview of the postulated mechanisms linking cancer and thrombosis. ten Cate H; Falanga A Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients. Falanga A; Schieppati F; Russo L Cancer Treat Res; 2019; 179():11-36. PubMed ID: 31317478 [TBL] [Abstract][Full Text] [Related]
11. Update on tumor cell procoagulant factors. Gale AJ; Gordon SG Acta Haematol; 2001; 106(1-2):25-32. PubMed ID: 11549774 [TBL] [Abstract][Full Text] [Related]
12. The role of procoagulants and anticoagulants in the development of venous thromboembolism. Bertina RM Thromb Res; 2009; 123 Suppl 4():S41-5. PubMed ID: 19303503 [TBL] [Abstract][Full Text] [Related]
18. 2013 scientific sessions Sol Sherry distinguished lecture in thrombosis: polyphosphate: a novel modulator of hemostasis and thrombosis. Smith SA; Morrissey JH Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1298-305. PubMed ID: 25908762 [TBL] [Abstract][Full Text] [Related]
19. Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer. Falanga A; Schieppati F; Russo D Semin Thromb Hemost; 2015 Oct; 41(7):756-64. PubMed ID: 26408922 [TBL] [Abstract][Full Text] [Related]
20. The prothrombotic state in cancer: pathogenic mechanisms. De Cicco M Crit Rev Oncol Hematol; 2004 Jun; 50(3):187-96. PubMed ID: 15182825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]